Management of Persistent Infectious Colitis with Fever and Profuse Watery Diarrhea
For this 40-year-old male with persistent symptoms of infectious colitis including high fever (103°F), severe abdominal cramping, and profuse watery diarrhea despite initial supportive care, empiric antibiotic therapy should be initiated immediately while awaiting stool culture results, using either azithromycin 1000 mg as a single dose or a fluoroquinolone (ciprofloxacin 500 mg twice daily for 5-7 days) to cover invasive bacterial pathogens. 1, 2
Clinical Assessment and Diagnostic Approach
The presence of high fever (103°F), severe abdominal pain, and CT-confirmed colitis indicates inflammatory infectious colitis requiring immediate evaluation beyond supportive care alone. 1
Key diagnostic steps to perform now:
Send stool for multiplex PCR testing (preferred over standard culture) to identify bacterial pathogens including Campylobacter, Salmonella, Shigella, and Shiga toxin-producing E. coli (STEC), as well as Clostridioides difficile toxin assay. 1, 3
Check for inflammatory markers in stool: fecal leukocytes, lactoferrin, or calprotectin to confirm inflammatory colitis. 1, 2
Obtain blood cultures if the patient appears systemically ill with persistent high fever, as bacteremia can complicate invasive bacterial enterocolitis. 1
Test specifically for C. difficile given the severity and persistence of symptoms, even without recent antibiotic exposure, as this can present with severe colitis. 1
Empiric Antibiotic Therapy
Do not wait for culture results before starting antibiotics in this patient with severe, persistent symptoms. The presence of fever >103°F, severe abdominal pain, and CT-confirmed colitis for multiple days warrants immediate empiric treatment. 1, 2
First-line empiric options:
Azithromycin 1000 mg as a single oral dose is the preferred empiric treatment for febrile dysenteric diarrhea covering Shigella, Salmonella, and Campylobacter. 2
Alternative: Ciprofloxacin 500 mg orally twice daily for 5-7 days if fluoroquinolone resistance is unlikely (patient has no recent international travel and local resistance rates <10%). 1, 4
Important caveats:
If Shiga toxin-producing E. coli (STEC/E. coli O157:H7) is suspected (bloody diarrhea with minimal or no fever), do NOT give antibiotics as they may increase risk of hemolytic uremic syndrome by inducing Shiga toxin release. 1
If C. difficile is confirmed, switch to oral vancomycin 125 mg four times daily for 10 days or fidaxomicin 200 mg twice daily for 10 days. 1
Supportive Care Optimization
Aggressive oral rehydration therapy (ORT) remains the cornerstone even when antibiotics are added. 1
Administer 2-4 liters of reduced-osmolarity oral rehydration solution (ORS) over 3-4 hours for moderate dehydration in adults. 1
Consider nasogastric ORS administration if the patient cannot tolerate adequate oral intake but is not severely dehydrated. 1
Escalate to intravenous hydration if signs of severe dehydration develop (altered mental status, severe orthostatic hypotension, inability to maintain oral intake). 1
Antiemetic therapy (ondansetron) can be used if nausea/vomiting limits oral intake. 1
Avoid antimotility agents (loperamide) in patients with high fever and inflammatory colitis, as they may worsen outcomes and increase risk of toxic megacolon. 1
Monitoring and Follow-Up
Clinical improvement should occur within 3-5 days of appropriate antibiotic therapy. 1, 5
Red flags requiring urgent reassessment:
Persistent fever beyond 72 hours on appropriate antibiotics suggests either resistant organism, inadequate source control, or complications (abscess, toxic megacolon). 5, 3
Worsening abdominal pain or distension may indicate toxic megacolon or perforation requiring surgical consultation. 1, 3
Development of bloody diarrhea if not initially present, or increasing blood in stool. 1
Antibiotic adjustment based on culture results:
De-escalate to narrow-spectrum therapy once specific pathogen and sensitivities are identified (typically within 24-48 hours with multiplex PCR). 1, 5
For confirmed Campylobacter: azithromycin 500 mg daily for 3 days or ciprofloxacin 500 mg twice daily for 5-7 days (if susceptible). 1
For confirmed Salmonella or Shigella: ciprofloxacin 500 mg twice daily for 5-7 days or azithromycin 500 mg daily for 3 days. 1, 2
For confirmed C. difficile: oral vancomycin 125 mg four times daily for 10 days (first-line) or fidaxomicin 200 mg twice daily for 10 days. 1
Common Pitfalls to Avoid
Do not withhold antibiotics in patients with severe inflammatory colitis (high fever, severe pain, CT-confirmed colitis) while waiting for culture results, as this delays appropriate therapy and worsens outcomes. 1, 2
Do not give antibiotics empirically for mild watery diarrhea without fever or inflammatory features, as most cases are viral and antibiotics provide no benefit while increasing resistance and C. difficile risk. 1
Do not use fluoroquinolones if STEC is suspected (bloody diarrhea with minimal fever), as antibiotics may precipitate hemolytic uremic syndrome. 1
Do not continue antibiotics beyond 5-7 days for most bacterial colitis once clinical improvement occurs, as longer courses do not improve outcomes and increase adverse effects. 1, 5
Do not assume treatment failure if diarrhea persists for several days after starting antibiotics, as complete resolution typically takes 5-7 days even with appropriate therapy. 1, 3